{"id":"https://openalex.org/W969182379","doi":"https://doi.org/10.1016/s0065-230x(08)60343-7","title":"1,3-Bis(2-Chloroethyl)-1-Nitrosourea (Bcnu) And Other Nitrosoureas In Cancer Treatment: A Review","display_name":"1,3-Bis(2-Chloroethyl)-1-Nitrosourea (Bcnu) And Other Nitrosoureas In Cancer Treatment: A Review","alternate_titles":[],"publication_year":1973,"publication_date":"1973-01-01","ids":{"openalex":"https://openalex.org/W969182379","doi":"https://doi.org/10.1016/s0065-230x(08)60343-7","mag":"969182379","pmid":"https://pubmed.ncbi.nlm.nih.gov/4563045"},"language":"en","primary_location":{"id":"doi:10.1016/s0065-230x(08)60343-7","doi":"https://doi.org/10.1016/s0065-230x(08)60343-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0065-230x(08)60343-7","pdf_url":null,"source":{"id":"https://openalex.org/S169378627","display_name":"Advances in cancer research","issn_l":"0065-230X","issn":["0065-230X","2162-5557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Cancer Research","raw_type":"book-chapter"},"parent_works":[{"id":"https://openalex.org/W4256134561","display_name":null,"relationship":"volume","link_type":"volume"}],"lineage":["https://openalex.org/W969182379","https://openalex.org/W4256134561"],"child_works_count":0,"type":"book-chapter","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111617693","display_name":"Stephen K. Carter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen K. Carter","raw_affiliation_strings":["Cancer Therapy Evaluation Branch, National Cancer Institute, Betherda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Therapy Evaluation Branch, National Cancer Institute, Betherda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109888706","display_name":"Frank M. Schabel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108109523","display_name":"Southern Research Institute","ror":"https://ror.org/0153ngy95","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I108109523"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Frank M. Schabel","raw_affiliation_strings":["Cancer Therapy Evaluation Branch, Southern Research Institute, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Therapy Evaluation Branch, Southern Research Institute, Birmingham, Alabama","institution_ids":["https://openalex.org/I108109523"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068552371","display_name":"Lawrence E. Broder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lawrence E. Broder","raw_affiliation_strings":["Cancer Therapy Evaluation Branch, National Cancer Institute, Betherda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Therapy Evaluation Branch, National Cancer Institute, Betherda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013584043","display_name":"Thomas Patrick Johnston","orcid":"https://orcid.org/0000-0003-4666-5334","observed_orcids":["https://orcid.org/0000-0003-4666-5334"]},"institutions":[{"id":"https://openalex.org/I108109523","display_name":"Southern Research Institute","ror":"https://ror.org/0153ngy95","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I108109523"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas P. Johnston","raw_affiliation_strings":["Cancer Therapy Evaluation Branch, Southern Research Institute, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Therapy Evaluation Branch, Southern Research Institute, Birmingham, Alabama","institution_ids":["https://openalex.org/I108109523"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":12.301,"has_fulltext":false,"cited_by_count":178,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.9919598,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"16","issue":null,"first_page":"273","last_page":"332"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/1-3-bis-2-chloroethyl-1-nitrosourea","display_name":"1,3-bis(2-chloroethyl)-1-nitrosourea","score":0.9850000143051147},{"id":"https://openalex.org/keywords/carmustine","display_name":"BCNU","score":0.9279999732971191},{"id":"https://openalex.org/keywords/nitrosourea","display_name":"nitrosourea","score":0.9769999980926514},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.8669999837875366},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.6769999861717224},{"id":"https://openalex.org/keywords/l1210-cells","display_name":"L1210 leukemia","score":0.7609999775886536},{"id":"https://openalex.org/keywords/veterinary-toxicology","display_name":"veterinary toxicology","score":0.6790000200271606},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.7269999980926514},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.7160000205039978}],"concepts":[{"id":"https://openalex.org/C2776946711","wikidata":"https://www.wikidata.org/wiki/Q418311","display_name":"Nitrosourea","level":3,"score":0.723290205001831},{"id":"https://openalex.org/C2780147359","wikidata":"https://www.wikidata.org/wiki/Q415869","display_name":"Carmustine","level":4,"score":0.6439841985702515},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5409736037254333},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.509479820728302},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.49613913893699646},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48693907260894775},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4313046336174011},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39233478903770447},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34362712502479553},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2379736304283142},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.07735854387283325}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002330","descriptor_name":"Carmustine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002330","descriptor_name":"Carmustine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002330","descriptor_name":"Carmustine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002474","descriptor_name":"Cell-Free System","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002621","descriptor_name":"Chemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007939","descriptor_name":"Leukemia L1210","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008815","descriptor_name":"Mice, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009316","descriptor_name":"National Institutes of Health (U.S.)","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009607","descriptor_name":"Nitrosourea Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009607","descriptor_name":"Nitrosourea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009607","descriptor_name":"Nitrosourea Compounds","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D012513","descriptor_name":"Sarcoma, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055598","descriptor_name":"Chemical Phenomena","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0065-230x(08)60343-7","doi":"https://doi.org/10.1016/s0065-230x(08)60343-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0065-230x(08)60343-7","pdf_url":null,"source":{"id":"https://openalex.org/S169378627","display_name":"Advances in cancer research","issn_l":"0065-230X","issn":["0065-230X","2162-5557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Cancer Research","raw_type":"book-chapter"},{"id":"pmid:4563045","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/4563045","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in cancer research","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":54,"referenced_works":["https://openalex.org/W1233276","https://openalex.org/W174188150","https://openalex.org/W249628473","https://openalex.org/W1430759985","https://openalex.org/W1479720950","https://openalex.org/W1509685506","https://openalex.org/W1519899626","https://openalex.org/W1522636858","https://openalex.org/W1555327017","https://openalex.org/W1596145695","https://openalex.org/W1602394852","https://openalex.org/W1609440971","https://openalex.org/W1727030015","https://openalex.org/W1736963549","https://openalex.org/W1787849830","https://openalex.org/W1795885442","https://openalex.org/W1857534425","https://openalex.org/W1923803416","https://openalex.org/W1935300038","https://openalex.org/W1941456061","https://openalex.org/W1974731171","https://openalex.org/W1977919029","https://openalex.org/W1981863853","https://openalex.org/W1982172413","https://openalex.org/W1988210681","https://openalex.org/W1995983979","https://openalex.org/W2013903319","https://openalex.org/W2015007522","https://openalex.org/W2025331743","https://openalex.org/W2066496934","https://openalex.org/W2066924057","https://openalex.org/W2069737659","https://openalex.org/W2072855897","https://openalex.org/W2103098314","https://openalex.org/W2156073846","https://openalex.org/W2157437053","https://openalex.org/W2161314918","https://openalex.org/W2167735418","https://openalex.org/W2169083993","https://openalex.org/W2313086702","https://openalex.org/W2315737152","https://openalex.org/W2329104419","https://openalex.org/W2330191029","https://openalex.org/W2336667149","https://openalex.org/W2401428473","https://openalex.org/W2403736537","https://openalex.org/W2409186476","https://openalex.org/W2409442153","https://openalex.org/W2410939283","https://openalex.org/W2412582724","https://openalex.org/W2415622130","https://openalex.org/W2419279105","https://openalex.org/W2422795159","https://openalex.org/W4407042757"],"related_works":["https://openalex.org/W1602394852","https://openalex.org/W166730528","https://openalex.org/W2071707384","https://openalex.org/W1522636858","https://openalex.org/W2333175709","https://openalex.org/W394249887","https://openalex.org/W1887445736","https://openalex.org/W203541975","https://openalex.org/W2408856151","https://openalex.org/W2297043150"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W969182379","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
